Berlin - Delayed Quote EUR
AbbVie Inc (4AB.BE)
175.40
+4.20
+(2.45%)
At close: May 2 at 9:48:20 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
18,806,000
18,806,000
22,839,000
24,943,000
22,777,000
Investing Cash Flow
-20,820,000
-20,820,000
-2,009,000
-623,000
-2,344,000
Financing Cash Flow
-5,211,000
-5,211,000
-17,222,000
-24,803,000
-19,039,000
End Cash Position
5,524,000
5,524,000
12,814,000
9,201,000
9,746,000
Income Tax Paid Supplemental Data
4,064,000
4,064,000
4,702,000
2,988,000
3,648,000
Interest Paid Supplemental Data
2,811,000
2,811,000
2,469,000
2,546,000
2,712,000
Capital Expenditure
-974,000
-974,000
-777,000
-695,000
-787,000
Issuance of Debt
21,971,000
21,971,000
--
2,000,000
1,000,000
Repayment of Debt
-14,621,000
-14,621,000
-4,149,000
-14,433,000
-9,414,000
Repurchase of Capital Stock
-1,708,000
-1,708,000
-1,972,000
-1,487,000
-934,000
Free Cash Flow
17,832,000
17,832,000
22,062,000
24,248,000
21,990,000
12/31/2021 - 2/14/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DSKYF Daiichi Sankyo Company, Limited
26.00
-0.19%
DSNKY Daiichi Sankyo Company, Limited
25.91
-0.12%
NOVN.SW Novartis AG
94.21
+0.45%
AZN.L AstraZeneca PLC
10,754.00
+1.38%
ROG.SW Roche Holding AG
272.40
+1.15%
NVS Novartis AG
114.29
+2.66%
GILD Gilead Sciences, Inc.
103.68
+0.42%
JNJ Johnson & Johnson
156.12
+1.07%
LLY Eli Lilly and Company
823.62
+3.72%
NVO Novo Nordisk A/S
69.23
+5.53%